NL7305034A - - Google Patents

Info

Publication number
NL7305034A
NL7305034A NL7305034A NL7305034A NL7305034A NL 7305034 A NL7305034 A NL 7305034A NL 7305034 A NL7305034 A NL 7305034A NL 7305034 A NL7305034 A NL 7305034A NL 7305034 A NL7305034 A NL 7305034A
Authority
NL
Netherlands
Application number
NL7305034A
Other versions
NL174620C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25763091&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL7305034(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE2218831A external-priority patent/DE2218831C3/de
Application filed filed Critical
Publication of NL7305034A publication Critical patent/NL7305034A/xx
Application granted granted Critical
Publication of NL174620C publication Critical patent/NL174620C/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NLAANVRAGE7305034,A 1972-04-14 1973-04-11 Verpakkingseenheid, welke een anticonceptivum bevat. NL174620C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2218831A DE2218831C3 (de) 1972-04-14 1972-04-14 Verwendung von Hormonen zur Kontrazeption
DE19732310963 DE2310963A1 (de) 1972-04-14 1973-03-02 Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten

Publications (2)

Publication Number Publication Date
NL7305034A true NL7305034A (sv) 1973-10-16
NL174620C NL174620C (nl) 1984-07-16

Family

ID=25763091

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7305034,A NL174620C (nl) 1972-04-14 1973-04-11 Verpakkingseenheid, welke een anticonceptivum bevat.

Country Status (7)

Country Link
US (1) US3939264A (sv)
BE (1) BE798185A (sv)
DE (1) DE2310963A1 (sv)
DK (1) DK141354C (sv)
GB (1) GB1433032A (sv)
NL (1) NL174620C (sv)
SE (1) SE443508B (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2365103C3 (de) * 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
NL8001593A (nl) * 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
US4289762A (en) * 1980-06-27 1981-09-15 Merrell Dow Pharmaceuticals Inc. 10-(1,2-Propadienyl) steroids as irreversible aromatase inhibitors
DE3029726A1 (de) * 1980-08-06 1982-02-25 Werner Dr.med. 4400 Münster Steinschulte Postkoitale kontrazeptiva mit norgestrel oder levonorgestrel
US5010070A (en) * 1987-06-15 1991-04-23 Warner-Lambert Company Graduated estrogen contraceptive
US4762717A (en) * 1986-03-21 1988-08-09 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
IE61236B1 (en) † 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
GB2217988B (en) * 1988-04-11 1992-04-01 Gould Leonard W Regimen for increasing bone density in humans
US5433219A (en) * 1992-09-23 1995-07-18 Spery; Nanette S. Receptive condom assembly
ZA939565B (en) † 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US6214815B1 (en) 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
JP2004140323A (ja) * 2002-08-20 2004-05-13 Sharp Corp 半導体レーザ装置およびその製造方法
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
CA2521471A1 (en) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Methods of administering estrogens and progestins
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6615481A (sv) * 1966-11-02 1968-05-03
US3568828A (en) * 1967-03-01 1971-03-09 Squibb & Sons Inc Modified sequential oral contraceptive
US3639600A (en) * 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
US3795734A (en) * 1970-04-20 1974-03-05 American Home Prod Cyclic regimen of hormone administration for contraception
US3733407A (en) * 1971-08-25 1973-05-15 Syntex Corp Menopause treatment

Also Published As

Publication number Publication date
NL174620C (nl) 1984-07-16
DE2310963A1 (de) 1974-09-05
DK141354B (da) 1980-03-03
SE443508B (sv) 1986-03-03
GB1433032A (en) 1976-04-22
BE798185A (fr) 1973-10-15
DK141354C (da) 1980-09-01
US3939264A (en) 1976-02-17

Similar Documents

Publication Publication Date Title
FR2169073A1 (sv)
FR2187852A1 (sv)
JPS498111A (sv)
JPS4887864U (sv)
JPS5226940Y2 (sv)
JPS5229802Y2 (sv)
JPS5526482B2 (sv)
HU167273B (sv)
JPS4918821U (sv)
JPS49100808U (sv)
JPS4895928U (sv)
JPS4983824A (sv)
JPS4982865U (sv)
CH585306B5 (sv)
CH581071A5 (sv)
BG19428A1 (sv)
BG17226A1 (sv)
BG18386A1 (sv)
BG18373A1 (sv)
CH575633A5 (sv)
CH591445A5 (sv)
CH590812A5 (sv)
CH589728A5 (sv)
CH586759A5 (sv)
CH576979A5 (sv)

Legal Events

Date Code Title Description
V4 Discontinued because of reaching the maximum lifetime of a patent